CompBrief BY VELARION

Companies Kala BIO, Inc.

Kala BIO CEO salary & total pay, FY2025: $907K

Kala BIO (KALA) CEO salary, fiscal 2025: Mark Iwicki (Former CEO) was paid a salary of $111,866 and $906,642 in total compensation. Free brief. Every figure links to the company’s own filing.

Velarion Intel: free for 3 days, no card →

Email me Kala BIO, Inc.’s executive pay brief as a PDF

You get it on this page the moment you ask; press Download and a copy goes to your email too. Every figure is cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

Also free: The Pay Desk, the weekly executive pay briefing.

Mark Iwicki's complete compensation dossier

A PDF and a CSV sent to your email: Mark Iwicki's pay in every fiscal year Kala BIO, Inc. reported it, line by line, with Mark Iwicki's equity grants and Kala BIO, Inc.'s disclosed peer group where the company discloses them. Every row is cited to its filing.

One-time report. No refunds.

See an example →
CEO total pay$906,642Former CEO Mark Iwicki · source
Say-on-pay support96.72%Latest vote · source
CEO vs. named peers1st pct.Against its disclosed peer group

CEO pay, last three years

  • $8,342,714FY2023
  • $1,491,187FY2024
  • $906,642FY2025

CEO total pay was $906,642 in fiscal 2025, down from $1,491,187 in fiscal 2024.

FY2025: salary $111,866 · bonus $0 · stock awards $166,413 · option awards $627,467

Executives and directors

Frequently asked questions

Who was the highest-paid executive at Kala BIO, Inc. in fiscal 2025?
As disclosed, Todd Bazemore (Former Interim Chief Executive Officer, President and Chief Operating Officer) was the highest-paid executive at Kala BIO, Inc. in fiscal 2025, with total compensation of $3,476,972.
How does Kala BIO, Inc.'s chief executive pay compare to its disclosed peer group?
As disclosed, Mark Iwicki's total compensation ranked at the 1st percentile of Kala BIO, Inc.'s disclosed peer group.
How did shareholders vote on Kala BIO, Inc.'s executive compensation?
As disclosed, 96.72% of shareholders supported Kala BIO, Inc.'s executive compensation in the latest say-on-pay vote.
How much does Kala BIO, Inc. spend in total on board compensation for fiscal 2025?
As disclosed, Kala BIO, Inc. reported total board compensation of $485,064 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Todd Bazemore$489,112$585,450$76,053$2,262,211$0$0$64,146$3,476,972
Former Interim Chief Executive Officer, President and Chief Operating Officer
Kim Brazzell420,000522,00076,053285,0400055,0811,358,174
Former Head of Research and Development and Chief Medical Officer
Mary Reumuth438,962475,55076,053285,0400047,0021,322,608
Former Chief Financial Officer
Mark Iwicki111,8660166,413627,46700896906,642
Former Chief Executive Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Todd Bazemore$3,476,972$949,550$2,943,656↑ +2,527,422
Kim Brazzell1,358,174920,6872,923,073↑ +437,487
Mary Reumuth1,322,608778,269—↑ +544,339
Mark Iwicki906,6421,491,1878,342,714↓ −584,545

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

The company uses base salaries to recognize experience, skills, and responsibilities, and performance-based bonuses to motivate employees to achieve annual goals based on strategic, financial, and operating performance objectives. Equity grants are utilized to create a strong link to long-term performance, foster an ownership culture, and align executive interests with stockholders.

CEO STI target (% of salary)—
CEO LTI target (% of salary)—
Independent consultantPearl Meyer & Partners, LLC
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingfalse
Equity grants and outstanding awards

No plan-based awards are on file for this fiscal year.

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardExercisableShares unvestedExercise priceMarket value unvested
Kim BrazzellOption38,388—14.56—
Kim BrazzellOption12,819—7—
Kim BrazzellOption8,475—7.53—
Mark IwickiRSU—13,903—7,730
Mark IwickiRSU—2,584—1,437
Mark IwickiRSU—52,969—29,451
Mark IwickiRSU—9,534—5,301
Mark IwickiRSU—22,100—12,288
Mark IwickiRSU—2,450—1,362
Mark IwickiOption132,39479,43714.56—
Mark IwickiOption30,90633,5947—
Mark IwickiOption22,80276,6987.53—
Mark IwickiOption—5,4504.3—
Mary ReumuthRSU—10,100—5,616
Mary ReumuthRSU—3,176—1,766
Mary ReumuthRSU—512—285
Mary ReumuthRSU—12,051—6,700
Mary ReumuthRSU—3,067—1,705
Mary ReumuthOption30,12018,07214.56—
Mary ReumuthOption9,82310,6777—
Mary ReumuthOption10,35834,8427.53—
Todd BazemoreRSU—4,268—2,373
Todd BazemoreRSU—794—441
Todd BazemoreRSU—16,236—9,027
Todd BazemoreRSU—4,334—2,410
Todd BazemoreOption40,58224,34914.56—
Todd BazemoreOption14,04015,2607—
Todd BazemoreOption10,35834,8427.53—
Todd BazemoreOption37,6677,5337.05—
Todd BazemoreOption15,000165,00011.22—
Todd BazemoreRSU—10,100—5,616
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Andrew I. KovenIndependent · Not standing for re-election · Departed during FY$96,298$13,115$24,628——$134,041
Howard B. RosenIndependent · Not standing for re-election · Departed during FY75,00010,53519,595——105,130
Mark IwickiEmployee director · Not standing for re-election · Departed during FY68,13910,53519,595——98,269
C. Daniel MyersIndependent · Not standing for re-election · Departed during FY67,50010,53519,595——97,630
Marjan FaridIndependent · Not standing for re-election · Departed during FY67,50010,53519,595——97,630
Gregory D. PerryIndependent · Compensation · Not standing for re-election · Departed during FY44,83710,53519,595——74,967

Board fee structure and ownership guideline

Annual cash retainer$50,000
Annual equity retainer—
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)20,000 / 15,000 / 10,000
Stock ownership guideline—

Total cost of the board

ComponentFY2025
Cash retainers and fees$419,274
Equity awards (grant-date value)$65,790
All other compensation$0
Total cost of the board$485,064

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Kala BIO as a peer

Companies that benchmark against KALA

2 companies name KALA as a compensation peer

Each company listed discloses KALA in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named KALA in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Kala BIO, Inc.2025Mark Iwicki$111,866$166,413$627,467$0$906,642

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-01-309,339,335317,19219,45896.72%Passed
20242024-06-11764,305225,45924,24077.22%Passed
20232023-06-22498,05457,91215,18589.58%Passed
20222022-10-19—————
20212021-06-17—————
2020——————

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
2020——a
20262026-01-3096.72%b
20242024-06-1177.22%c

a. Voting standard not stated in the filing.

b. Approved under the standard stated in the filing — “5 Proposal 2 - Advisory Vote on Executive Compensation The affirmative vote of the holders of shares of common stock representing a majority of the votes cast by holders of all shares of common stock present in person or represented by proxy at the meeting and voting affirmatively or negatively on Proposal 2 is required for approval of the advisory vote on executive compensation. || Abstentions: Shares that abstain from voting and broker non-votes are not votes cast and will not be counted as votes cast or voting on Proposal 2.”.

c. Approved under the standard stated in the filing — “Accordingly, abstentions and broker non-votes will have no effect on the voting on Proposal 2.”.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

Insider trades since the proxy

No insider equity transactions reported since the proxy statement.

Sources (16 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, Todd Bazemore. DEF 14A, filed 2026-09-24. Section “Executive Compensation”. As printed: 3,476,972. View filing ↗
  • Section 01, Kim Brazzell. DEF 14A, filed 2026-09-24. Section “Executive Compensation”. As printed: 1,358,174. View filing ↗
  • Section 01, Mary Reumuth. DEF 14A, filed 2026-09-24. Section “Executive Compensation”. As printed: 1,322,608. View filing ↗
  • Section 01, Mark Iwicki. DEF 14A, filed 2026-09-24. Section “Executive Compensation”. As printed: 906,642. View filing ↗
  • Section 08, Andrew I. Koven. DEF 14A, filed 2026-09-24. Section “Director Compensation”. As printed: 134,041. View filing ↗
  • Section 08, Howard B. Rosen. DEF 14A, filed 2026-09-24. Section “Director Compensation”. As printed: 105,130. View filing ↗
  • Section 08, Mark Iwicki. DEF 14A, filed 2026-09-24. Section “Director Compensation”. As printed: 98,269. View filing ↗
  • Section 08, C. Daniel Myers. DEF 14A, filed 2026-09-24. Section “Director Compensation”. As printed: 97,630. View filing ↗
  • Section 08, Marjan Farid. DEF 14A, filed 2026-09-24. Section “Director Compensation”. As printed: 97,630. View filing ↗
  • Section 08, Gregory D. Perry. DEF 14A, filed 2026-09-24. Section “Director Compensation”. As printed: 74,967. View filing ↗
  • Section 06, 2020 vote. Form 8-K, filed 2020-11-05. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
  • Section 06, 2026 vote. Form 8-K, filed 2026-02-02. Item 5.07 · say-on-pay result. As reported: 96.72% (votes for as printed: 9,339,335). View filing ↗
  • Section 06, 2024 vote. Form 8-K, filed 2024-06-12. Item 5.07 · say-on-pay result. As reported: 77.22% (votes for as printed: 764,305). View filing ↗
  • Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
  • Section 09b board cost (computed). Computed. Cash 419,274 + equity 65,790 + all other 0 = 485,064, summed across the director compensation table rows.
  • Kala BIO, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-09-24. CEO total compensation as printed in Kala BIO, Inc.'s own proxy. As printed: 906,642. View filing ↗
Get the full report — $299